Who owns Corcept Therapeutics Incorporated?

Key details on Corcept Therapeutics Incorporated (Ticker: CORT)

Who owns Corcept Therapeutics Incorporated?

Is CORT a good stock to own? Find out who bought Corcept Therapeutics Incorporated, who sold Corcept Therapeutics Incorporated (CORT) stock, and who holds a large position in Corcept Therapeutics Incorporated.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 14.19M $70.66M Dec. 31, 2015
TimesSquare Capital Management 4.10M $11.45M Sept. 30, 2012
TCW 3.28M $9.16M Sept. 30, 2012
Vanguard 2.76M $13.75M Dec. 31, 2015
Credit Suisse AG 2.73M $7.61M Sept. 30, 2012
BlackRock Institutional Trust Company, N.A. 2.55M $12.69M Dec. 31, 2015
Jennison Associates 2.15M $9.38M March 31, 2014
MORGAN STANLEY 2.07M $10.29M Dec. 31, 2015
Investor AB 1.83M $9.12M Dec. 31, 2015
BlackRock Fund Advisors 1.68M $8.35M Dec. 31, 2015
First Eagle Investment Management 991978 $3.19M Dec. 31, 2013
STATE STREET CORPORATION 868791 $4.32M Dec. 31, 2015

Who sold Corcept Therapeutics Incorporated?

Fund Name Date Sold Number of Shares Sold Share Valuation
Adage Capital Partners GP March 31, 2013 1.01M $2.03M
Franklin Resources March 31, 2011 988800 $4.20M
Maverick Capital March 31, 2008 1.38M $4.43M